Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease
To access this article, please choose from the options below
We gratefully acknowledge the financial support of the Deseret Foundation, Salt Lake City, Utah, and National Heart, Lung, and Blood Institute grant 1 R01 4L071878-01A2.
PII: S0002-8703(04)00595-2
doi:10.1016/j.ahj.2004.08.034
© 2005 Mosby, Inc. All rights reserved.
